Michael McDonell, PhD

Personal Statement

My primary interest is on determining how behavioral technologies can be used to improve alcohol and drug abuse outcomes for those suffering from addiction health disparities. Behavioral technologies are non-talk therapy approaches to addiction treatment, such as motivational incentives where we provide rewards for people who abstain from or reduce their drinking. This low-cost, strength based approach to addiction can be implemented in low-resources settings by non clinicians. In fact, our group is investigating how smartphones might be used to implement this treatment, allowing us to reach the millions of individuals suffering from alcohol problems worldwide.  

My second research interest in evaluating the accuracy of alcohol biomarkers in addiction treatment settings. These include alcohol urine tests, such as ethyl glucuronide (EtG) and mobile phone linked Bluetooth breathalyzers. These tools allow us to accurately assess  the success of alcohol treatments, as well as provide valuable research tools.      

Importantly all of my research studies are conducted in collaboration with two communities that suffer disproportionately high rates of alcohol and drug misuse, 1) adults with severe mental illnesses, like schizophrenia and bipolar disorder and 2) American Indians and Alaska Natives. My research team and I work closely with community partners who are providing addiction treatment to these populations with the goal of reducing the burden of alcohol and drug use in these communities. 

Recent Publications

Cross-sectional comparison of cannabis use in adults with neuropathic versus non-neuropathic pain.
(2025)
Front Pain Res (Lausanne) 6(): 1677391
Laroya CJP, Smith CL, Bindler RJ, McDonell MG, Lewis J, Wilson M

The pharmaceutically enhanced reinforcement for reduced alcohol and smoking (PERRAS) study: Protocol for a randomized clinical trial.
(2025 Dec 19)
Contemp Clin Trials 161(): 108189
Palombo P, Akana N, Bowen A, Schmidt A, Ryan R, Hovland S, Stark BC, Rodin N, Chaytor N, McDonell MG, Burduli E, Layton M, Roll JM, Smith CL, Miguel AQ, McPherson SM

Feasibility and acceptability study of an engagement intervention for family members in early intervention programs for psychosis.
(2025 Dec 3)
Schizophrenia (Heidelb) 12(1): 5
Oluwoye O, Stokes B, Garcia KS, Compton MT, Dyck DG, Lewis-Fernández R, McPherson SM, Cabassa LJ, McDonell MG

Bringing evidence-based stimulant treatment to permanent supportive housing.
(2025 Nov 13)
J Prev Interv Community
Peavy KM, Palmer K, Leickly E, Bains A, Parent S, McDonell MG

Risk Environments of Permanent Supportive Housing for Formerly Incarcerated People with Serious Mental Illnesses: A Protocol for a Novel Mixed Methods Feasibility Study.
(2025 Jan-Dec)
Int J Qual Methods 24():
Kriegel LS, Henwood BF, McDonell MG, Amram O, Bellamy C, Collins S, Salzer M

Show complete publication list »
Edit Profile